Nilofer Azad

Associate Professor

20022020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Review article
2020

Current and emerging therapies for patients with advanced pancreatic ductal adenocarcinoma: a bright future

Christenson, E. S., Jaffee, E. & Azad, N. S., Mar 2020, In : The Lancet Oncology. 21, 3, p. e135-e145

Research output: Contribution to journalReview article

Immune checkpoint inhibitor therapy in biliary tract cancer (cholangiocarcinoma)

Jakubowski, C. D. & Azad, N. S., Feb 1 2020, In : Chinese Clinical Oncology. 9, 1, 2.

Research output: Contribution to journalReview article

2019

Executive Summary of the American Radium Society Appropriate Use Criteria for Local Excision in Rectal Cancer

Expert Panel on Radiation Oncology- Local Excision in Rectal Cancer, Dec 1 2019, In : International Journal of Radiation Oncology Biology Physics. 105, 5, p. 977-993 17 p.

Research output: Contribution to journalReview article

Executive Summary of the American Radium Society Appropriate Use Criteria for Treatment of Anal Cancer

Russo, S., Anker, C. J., Abdel-Wahab, M., Azad, N., Bianchi, N., Das, P., Dragovic, J., Goodman, K. A., Jones, W., Kennedy, T., Kumar, R., Lee, P., Sharma, N., Small, W., Suh, W. W. & Jabbour, S. K., Nov 1 2019, In : International Journal of Radiation Oncology Biology Physics. 105, 3, p. 591-605 15 p.

Research output: Contribution to journalReview article

Precision Cancer Trials with Immunomodulatory Agents: Personalizing Histology Agnostic Approaches

Baretti, M. & Azad, N., Jul 1 2019, In : Cancer Journal (United States). 25, 4, p. 287-295 9 p.

Research output: Contribution to journalReview article

2018

Significance and implications of FDA approval of pembrolizumab for biomarker-defined disease

Boyiadzis, M. M., Kirkwood, J. M., Marshall, J. L., Pritchard, C. C., Azad, N. S. & Gulley, J. L., May 14 2018, In : Journal for immunotherapy of cancer. 6, 1, 35.

Research output: Contribution to journalReview article

2017

ACR Appropriateness Criteria ® Resectable Pancreatic Cancer

Jones, W. E., Suh, W. W., Abdel-Wahab, M., Abrams, R. A., Azad, N., Das, P., Dragovic, J., Goodman, K. A., Jabbour, S. K., Konski, A. A., Koong, A. C., Kumar, R., Lee, P., Pawlik, T. M., Small, W. & Herman, J. M., 2017, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 40, 2, p. 109-117 9 p.

Research output: Contribution to journalReview article

2016

ACR appropriateness criteria® borderline and unresectable pancreas cancer

Small, W., Hayes, J. P., Suh, W. W., May, A. W., Abrams, R. A., Azad, N., Das, P., Dragovic, J., Goodman, K. A., Jabbour, S. K., Jones, W. E., Konski, A. A., Koong, A. C., Kumar, R., Lee, P., Pawlik, T. M. & Herman, J. M., Jul 15 2016, In : Oncology. 30, 7

Research output: Contribution to journalReview article

2015

ACR Appropriateness Criteria® Local Excision in Early Stage Rectal Cancer

Russo, S., Blackstock, A. W., Herman, J. M., Abdel-Wahab, M., Azad, N., Das, P., Goodman, K. A., Hong, T. S., Jabbour, S. K., Jones, W. E., Konski, A. A., Koong, A. C., Kumar, R., Rodriguez-Bigas, M., Small, W., Thomas, C. R. & Suh, W. W., Oct 1 2015, In : American Journal of Clinical Oncology. 38, 5, p. 520-525 6 p.

Research output: Contribution to journalReview article

Epigenetic therapy for solid tumors: From bench science to clinical trials

Juo, Y. Y., Gong, X. J., Mishra, A., Cui, X., Baylin, S. B., Azad, N. S. & Ahuja, N., Apr 1 2015, In : Epigenomics. 7, 2, p. 215-235 21 p.

Research output: Contribution to journalReview article

2014

Emerging evidence for CHFR as a cancer biomarker: From tumor biology to precision medicine

Derks, S., Cleven, A. H. G., Melotte, V., Smits, K. M., Brandes, J. C., Azad, N., Van Criekinge, W., De Bruïne, A. P., Herman, J. G. & Van Engeland, M., Mar 2014, In : Cancer and Metastasis Reviews. 33, 1, p. 161-171 11 p.

Research output: Contribution to journalReview article

2013

The future of epigenetic therapy in solid tumours - Lessons from the past

Azad, N., Zahnow, C. A., Rudin, C. M. & Baylin, S. B., May 1 2013, In : Nature Reviews Clinical Oncology. 10, 5, p. 256-266 11 p.

Research output: Contribution to journalReview article

2012

ACR Appropriateness Criteria® Resectable Rectal Cancer

Jones, W. E., Thomas, C. R., Herman, J. M., Abdel-Wahab, M., Azad, N., Blackstock, W., Das, P., Goodman, K. A., Hong, T. S., Jabbour, S. K., Konski, A. A., Koong, A. C., Rodriguez-Bigas, M., Small, W., Zook, J. & Suh, W. W., Sep 24 2012, In : Radiation Oncology. 7, 1, 161.

Research output: Contribution to journalReview article

Reporting of preclinical tumor-graft cancer therapeutic studies

Sugar, E., Pascoe, A. J. & Azad, N., Nov 1 2012, In : Cancer Biology and Therapy. 13, 13, p. 1262-1268 7 p.

Research output: Contribution to journalReview article

2007

Proteomics as a tool for biomarker discovery

Kohn, E. C., Azad, N., Annunziata, C., Dhamoon, A. S. & Whiteley, G., Jan 1 2007, In : Disease Markers. 23, 5-6, p. 411-417 7 p.

Research output: Contribution to journalReview article

The ongoing evolution of proteomics in malignancy

Dhamoon, A. S., Kohn, E. C. & Azad, N. S., Sep 1 2007, In : Drug Discovery Today. 12, 17-18, p. 700-708 9 p.

Research output: Contribution to journalReview article

2006

Proteomics in clinical trials and practice: Present uses and future promise

Azad, N. S., Rasool, N., Annunziata, C. M., Minasian, L., Whiteley, G. & Kohn, E. C., Oct 1 2006, In : Molecular and Cellular Proteomics. 5, 10, p. 1819-1829 11 p.

Research output: Contribution to journalReview article